🇺🇸 PTGX — Protagonist Therapeutics, Inc.
Salud Compra fuertePrecio actual
143,37 USD
Máx. histórico
158,62
79 días
Caída desde máximo
-9,61%
Rango 52 semanas
75,55 – 160,81
Variación hoy
+2,23%
Cierre anterior
140,24
Rango de hoy
138,62 – 145,61
Volumen hoy
713.418
Peor caída histórica
-85,79%
01/09/2021 → 13/06/2022
Recuperado en 1001 días
Volatilidad anualizada ⓘ
89,33%
- Nombre completo
- Protagonist Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 141
- PER ⓘ
- 139,19 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 178,57 USD (puede no estar actualizado)
- Primera cotización
- 11/08/2016
- Precio actualizado
- hace 22 horas
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/11/2022 | 8,00 | 8,02 | 7,66 | 7,84 | -2,49% | 4,50% | 464.000 |
| 21/11/2022 | 8,06 | 8,09 | 7,78 | 8,04 | -0,50% | 3,85% | 784.700 |
| 18/11/2022 | 8,25 | 8,25 | 8,03 | 8,08 | +1,13% | 2,67% | 493.800 |
| 17/11/2022 | 7,95 | 8,02 | 7,72 | 7,99 | -0,25% | 3,71% | 761.500 |
| 16/11/2022 | 8,00 | 8,20 | 7,91 | 8,01 | -0,37% | 3,69% | 597.300 |
| 15/11/2022 | 8,58 | 8,58 | 7,83 | 8,04 | -3,25% | 8,74% | 745.700 |
| 14/11/2022 | 8,46 | 8,63 | 8,29 | 8,31 | -2,00% | 4,02% | 576.500 |
| 11/11/2022 | 8,42 | 8,61 | 8,15 | 8,48 | -0,59% | 5,46% | 507.600 |
| 10/11/2022 | 8,13 | 8,61 | 8,06 | 8,53 | +10,64% | 6,83% | 1.472.700 |
| 09/11/2022 | 7,88 | 8,40 | 7,69 | 7,71 | -0,39% | 9,01% | 957.900 |
| 08/11/2022 | 7,79 | 7,89 | 7,53 | 7,74 | -0,13% | 4,62% | 583.000 |
| 07/11/2022 | 7,94 | 8,07 | 7,73 | 7,75 | -1,65% | 4,28% | 756.900 |
| 04/11/2022 | 8,10 | 8,17 | 7,71 | 7,88 | +0,00% | 5,68% | 760.700 |
| 03/11/2022 | 7,93 | 8,15 | 7,86 | 7,88 | -2,60% | 3,66% | 522.300 |
| 02/11/2022 | 8,46 | 8,64 | 8,07 | 8,09 | -4,37% | 6,80% | 513.600 |
| 01/11/2022 | 8,25 | 8,63 | 8,15 | 8,46 | +4,44% | 5,82% | 529.700 |
| 31/10/2022 | 8,70 | 8,72 | 7,98 | 8,10 | -5,59% | 8,51% | 544.100 |
| 28/10/2022 | 8,32 | 8,62 | 8,15 | 8,58 | +4,38% | 5,65% | 652.400 |
| 27/10/2022 | 8,50 | 8,66 | 8,20 | 8,22 | -2,03% | 5,41% | 486.500 |
| 26/10/2022 | 8,39 | 8,66 | 8,27 | 8,39 | +0,48% | 4,65% | 1.035.600 |
| 25/10/2022 | 7,97 | 8,44 | 7,97 | 8,35 | +4,90% | 5,90% | 800.200 |
| 24/10/2022 | 8,32 | 8,32 | 7,88 | 7,96 | -3,52% | 5,29% | 409.700 |
| 21/10/2022 | 7,99 | 8,28 | 7,91 | 8,25 | +3,90% | 4,63% | 709.100 |
| 20/10/2022 | 8,02 | 8,37 | 7,94 | 7,94 | -0,75% | 5,36% | 408.600 |
| 19/10/2022 | 8,27 | 8,40 | 7,89 | 8,00 | -4,31% | 6,17% | 1.059.500 |
| 18/10/2022 | 8,44 | 8,53 | 8,21 | 8,36 | +1,21% | 3,79% | 372.100 |
| 17/10/2022 | 8,13 | 8,33 | 7,99 | 8,26 | +3,38% | 4,24% | 675.200 |
| 14/10/2022 | 8,39 | 8,51 | 7,94 | 7,99 | -4,20% | 6,79% | 593.400 |
| 13/10/2022 | 7,95 | 8,36 | 7,87 | 8,34 | +2,08% | 6,16% | 500.600 |
| 12/10/2022 | 8,18 | 8,25 | 7,98 | 8,17 | +0,12% | 3,30% | 547.000 |